Cytokinetics Presents New Data in Patients With : comparemel

Treatment of Aficamten was Well-Tolerated and Associated with Statistically Significant Improvements in KCCQ, Angina Frequency, NYHA Class, NTpro-BNP and...

Related Keywords

Prague , Praha , Hlavníesto , Czech Republic , Oregon , United States , China , Ahmad Masri , Fadyi Malik , Diane Weiser , Research Development , Cytokinetics Incorporated Nasdaq , Twitter , National Medical Products Administration , Youtube , Linkedin , International Congress , European Society Of Cardiology , Exchange Commission , Facebook , York Heart Association , Us Food Drug Administration , Corporate Communications , Statistically Significant Improvements , Angina Frequency , High Sensitivity Troponin , Randomized Evaluation , Dosing With , Obstructive Outflow Disease , Late Breaking Clinical Trial , Heart Failure , European Society , Cytokinetic Executive Vice President , Hypertrophic Cardiomyopathy Center , Oregon Health , Science University , Kansas City Cardiomyopathy Questionnaire , Clinical Symptom Score , New York Heart Association , Breakthrough Therapy Designation , Drug Administration , Private Securities Litigation Reform Act , Safe Harbor , Vice President , Nasdaq Cytk , Cytokinetics , Ncorporated ,